NCT04138498 - CTx-1301 Comparative Bioavailability Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

March 6, 2020

Study Completion Date

March 6, 2020

Conditions

ADHD

Interventions

DRUG

Dexmethylphenidate 5 Mg Oral Capsule, Extended Release

Reference listed drug (RLD) for comparative BA evaluation

DRUG

Dexmethylphenidate 6.25 mg Tablet

Experimental drug for comparative BA evaluation

DRUG

Dexmethylphenidate 40 Mg Oral Capsule, Extended Release

Reference listed drug (RLD) for comparative BA evaluation

DRUG

Dexmethylphenidate 50 mg Tablet

Experimental drug for comparative BA evaluation

Trial Locations (1)

Vince & Associates, Overland Park